Power3 Medical Using Biomarkers For Early Detection Of Neurodegenerative Diseases

HOUSTON--(BUSINESS WIRE)--May 16, 2006--Steven B. Rash, the CEO of Power3 Medical Products, Inc., a leading proteomics company that develops and commercializes early detection diagnostic tests for cancer and neurodegenerative diseases, doesn’t live up to his name . . . he doesn’t make “rash” statements. That’s one reason that he caused a bit of a stir recently in describing his company’s work by using a reference to an immensely popular book and upcoming movie.

MORE ON THIS TOPIC